BetterLife Pharma Inc.
BETRF OTC
SEC CIK 1464165
Follow BetterLife Pharma
Weekly email: filings, results
Net income
−$121.2K
+98.1% vs prior year
EPS, diluted
$0.00
+100% vs prior year
Operating cash flow
−$395.6K
−10.1% vs prior year
Operating income
−$1M
+82.6% vs prior year
Source: SEC XBRL filings · latest filing
Show the numbers
| Year | Net income |
|---|---|
| FY18 | −$121.2K |
| FY17 | −$6.3M |
| FY16 | −$10.3M |
| FY15 | −$1.1M |
| FY14 | - |
| FY13 | $341.4K |
| FY12 | $1.4M |
| FY11 | −$3M |
| FY10 | −$120.1K |
| FY09 | −$653.8K |
| FY08 | - |
| FY07 | - |